Peregrine Pharmaceuticals of Tustin, CA, has received additional time to regain compliance with Nasdaq's minimum bid price rule.
The company received a letter from the Nasdaq Stock Market that gives Peregrine until April 27, 2009, to regain compliance with Nasdaq's $1 minimum bid price rule in order to remain listed. The extension was granted as part of Nasdaq's recently announced temporary suspension of the minimum bid price and market value requirements for all of its listed companies.
Related Reading
Peregrine posts Q1 2009 results, September 10, 2008
Peregrine establishes Chinese subsidiary, sues CTL, January 12, 2007
Peregrine adds to coffers, June 24, 2005
Peregrine nets grant from Philip Morris, September 9, 2003
TNT gets clearance in China, August 13, 2003
Copyright © 2008 AuntMinnie.com
